G1 Therapeutics
GTHX
$4.49
Share price
1.13%
Change (1 day)
48.68%
Change (1 year)
Categories
G1 Therapeutics (GTHX) - Cash on Hand
Cash on Hand as of December 2023 : $82.15 M
According to G1 Therapeutics
's latest financial reports the company has $82.15 M in cash and cash equivalents.
A company’s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.
G1 Therapeutics - Cash on Hand chart (from 2016 to 2023)
Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023-12-31 | $82.15 M | -43.37% |
| 2022-12-31 | $0.14 B | -34.41% |
| 2021-12-31 | $0.22 B | 6.7% |
| 2020-12-31 | $0.20 B | -22.99% |
| 2019-12-31 | $0.26 B | -27.1% |
| 2018-12-31 | $0.36 B | 255.73% |
| 2017-12-31 | $0.10 B | 119.45% |
| 2016-12-31 | $47.3 M | 106.23% |
| 2015-12-31 | $22.93 M |
Cash on Hand for similar companies or competitors
| Company | Cash on Hand | differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | $0.20 B | 153.40% | 🇺🇸 USA |